drugset / Trial / NCT05088798

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

NCT05088798

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to provide access to 18F-DOPA PET to patients at Washington University and assess the utility of 18F-DOPA PET/MRI as a preoperative tool to detect and localize focal lesions in the pancreas that are causing hyperinsulinism.

Timeline

Start
2020-09-10
Primary completion
2030-01-01
Completion
2030-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DOPA Diagnostic / imaging agent

Indications